This article highlights the leadership role of an immunologist in driving prostate cancer advancements, indicating a significant voice in scientific innovation.
![Figure][1] Andrea Miyahira, PhD Andrea Miyahira, PhD, is Vice President of Global Research & Innovation at the Prostate Cancer Foundation (PCF) and also serves as Editor of the Translational Science in Prostate Cancer Center of Excellence and Women in Science Center of Excellence for
No takes yet. Share an insight, caveat, or question.
Miyahira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: